U.S. pharma big copyright scrapped two experimental weight loss products last yr—a at the time-daily pill, lotiglipron, resulting from elevated liver enzymes in addition to a 2 times-daily pill, danuglipron, as a result of potent Negative effects—but CEO Albert Bourla has explained the company is set to “Perform and get” inside the obesity